CorMatrixA Cardiovascular, Inc., a leading developer of biomaterials and medical devices, today announced the issuance of U.S. Patent Numbers: 8,568,761; 8,753,885; 8,734,841; 8,642,084; 8,771,737; 8,734,842; 8,753,886; 8,735,155; 8,771,737; 8,784,891; 8,785,197 and 8,785,198 directed to CorMatrix's novel augmented extracellular matrix bioscaffolds. The augmented ECMA bioscaffold tissue structures comprise various materials, including, but not limited to, small intestine, urinary bladder, liver, stomach, placental, and heart tissue, that are augmented with a variety of selective bioactive components, such as GAGs, FGF-2, TGF-I , TFG-I2, VEGF, cytokines and DNA.
http://ift.tt/1AL7ghQ
http://ift.tt/1AL7ghQ
No comments:
Post a Comment